Anti-proliferation

Przewaquinone A
Catalog No: CFN92022

Przewaquinone A has antitumor activity.

Vicenin -2
Catalog No: CFN92031

Vicenin -2 has hepatoprotective, anti-cancer, antioxidant and anti-inflammatory activities, and DTL co-administration is more effective than either of the single agents in androgen-independent prostate cancer. Vicenin -2 might be a useful lead for the development of multiple target-oriented therapeutic modalities for the treatment of diabetes and diabetes-associated complications. Vicenin -2 could act as a UV light barrier to protect the plants.

Delphinidin-3-O-glucoside chloride
Catalog No: CFN92038

Delphinidin-3-O-glucoside chloride has antioxidant activity.

Bursehernin
Catalog No: CFN92058

Bursehernin has potential for development as an anti-tumor agent with an anti-proliferation, and cell cycle arrest inducing.

Gambogenic acid
Catalog No: CFN92097

Gambogenic acid is an inhibitor of the FGFR signaling pathway in erlotinib-resistant non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects, it can cause aberrant autophagy to induce cell death and may suggest the potential application of Gambogenic acid as a tool or viable drug in anticancer therapies.Gambogenic acid could inhibit the proliferation of melanoma B16 cells and induce their apoptosis within certain time and concentration ranges. Its mechanism in inducing the cell apoptosis may be related to PI3K/Akt/mTOR signaling pathways.